Frances Stocks Allen is a Partner at Cooley LLP, representing public and private life sciences, biotech, pharmaceutical, and techbio clients in licensing, commercial, collaboration, and intellectual property matters. Her practice emphasizes pragmatic, business-oriented counsel on data, AI, platform, and therapeutics deals. Frances has advised on high-value partnerships, including deals in Treg cell therapies, drug divestments, strategic licensing, and privacy/data collaboration agreements. She frequently speaks on life sciences legal topics. She holds a BA in PPE from Oxford University, an MBA and legal qualifications from BPP University, and a Postgraduate Diploma in IP Law and Practice from Oxford.